Physician profile
Usman Khan
NPI 1578959300
$2,115.66
in general payments reported to CMS, 2019-2025
20 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $123 · 2021: $198 · 2022: $195 · 2023: $440 · 2024: $414 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $499.67 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $367.55 | 2019-2024 | |
| Janssen Biotech, INC. | $270.76 | 2021-2024 | Darzalex, Tecvayli, Imbruvica |
| Astrazeneca Pharmaceuticals Lp | $124.82 | 2023 | Lokelma |
| Seagen INC. | $101.10 | 2019-2022 | |
| Amgen INC. | $99.98 | 2019-2020 | |
| Abiomed | $92.32 | 2024 | Impella |
| Stryker Corporation | $86.67 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Glaxosmithkline, LLC. | $68.02 | 2022-2025 | Ojjaara, Blenrep |
| Bayer Healthcare Pharmaceuticals INC. | $62.32 | 2024-2025 | |
| Pfizer INC. | $61.90 | 2019-2020 | |
| Angiodynamics, INC. | $55.31 | 2025 | Alphavac |
| Abbott Laboratories | $48.06 | 2020-2021 | |
| Argon Medical Devices, INC. | $46.29 | 2023-2025 | Clot Management, Ivcf |
| Incyte Corporation | $43.41 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $33.48 | 2019 | |
| Organon LLC | $16.93 | 2025 | Jada System |
| Pharmacyclics LLC, An Abbvie Company | $14.39 | 2023 | Imbruvica |
| Janssen Pharmaceuticals, INC | $11.60 | 2020 | |
| Eisai INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.